Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
18%(2 trials)

Phase Distribution

Ph phase_3
7
64%
Ph phase_2
1
9%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
7(77.8%)
Phase 4Post-market surveillance
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(11)

Detailed Status

Completed11

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 37 (77.8%)
Phase 41 (11.1%)

Trials by Status

completed11100%

Recent Activity

0 active trials
Showing 5 of 11
completed

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

NCT00936676
completedphase_2

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

NCT00977665
completed

Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease

NCT01032486
completedphase_3

A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

NCT00256204
completedphase_3

A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.

NCT00203125
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00936676

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Completed
NCT00977665Phase 2

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Completed
NCT01032486

Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease

Completed
NCT00256204Phase 3

A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

Completed
NCT00203125Phase 3

A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.

Completed
NCT00203060Phase 3

Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

Completed
NCT00399477Phase 4

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Completed
NCT00203138Phase 3

Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease

Completed
NCT00203164Phase 3

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Completed
NCT00203177Phase 3

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Completed
NCT00203034Phase 3

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11